Atrial Fibrillation, Persistent Clinical Trial
Official title:
Noninvasive 3D Mapping in Persistent Atrial Fibrillation, to Describe Modifications of the Arrhythmogenic Substrate After Pulmonary Vein Isolation and Identify Potential Predicting Factors of Ablation Success
Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults. It is a major cause
of ischemic stroke and heart failure. Intravascular cardiac ablation of the left atrium by
catheter delivery is an efficient treatment to restore sinus rhythm. AF ablation is a class
IIa treatment for patients with symptomatic persistent AF refractory or intolerant to
antiarrhythmic medication. There are still many debates considering the ablation strategy.
The pulmonary veins remain the cornerstone of AF ablation therapy, even in persistent AF.
There is a large electrical remodeling occurring in the left atrium between paroxysmal AF,
early persistent AF and long-standing persistent AF. However, no multicentric and randomized
study has demonstrated so far the interest of targeting other left atrial substrate, such as
rotors or focal sources.
Our study aims to describe with a noninvasive mapping system the arrhythmogenic substrate of
persistent AF > 6 months pre- and post-cardioversion, and after pulmonary vein isolation.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04544397 -
Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
|
||
Completed |
NCT04473963 -
FLOW-AF: A Study to Evaluate the Ablacon Electrographic FLOW EGF Technology
|
N/A | |
Recruiting |
NCT04715425 -
Thoracoscopic Surgical Versus Catheter Ablation Approaches for Primary Treatment of Persistent Atrial Fibrillation
|
N/A | |
Completed |
NCT04045067 -
Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation
|
||
Enrolling by invitation |
NCT04148625 -
Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation
|
||
Active, not recruiting |
NCT05481359 -
AF-FLOW Registry: This Study is to Evaluate Ablamap Software in Patients Undergoing Ablation for Atrial Fibrillation.
|
||
Completed |
NCT06260670 -
FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
|
N/A | |
Recruiting |
NCT05883631 -
RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
|
N/A | |
Recruiting |
NCT04942834 -
Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation
|
N/A | |
Recruiting |
NCT04606693 -
Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates
|
N/A | |
Enrolling by invitation |
NCT04508491 -
Cognitive Function in Patients With Persisted Atrial Fibrillation
|
N/A | |
Active, not recruiting |
NCT05507749 -
Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring
|
N/A | |
Not yet recruiting |
NCT06098989 -
A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study)
|
N/A | |
Recruiting |
NCT05575557 -
Pulmonary Artery Pressure and Right Heart Evaluation for Patients Requiring Physiological Pacing Treatment
|
N/A | |
Recruiting |
NCT05411614 -
Hybrid AbLaTion of Atrial Fibrillation
|
N/A | |
Recruiting |
NCT04342312 -
Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
|
||
Recruiting |
NCT04542785 -
Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clinical Trial
|
N/A | |
Recruiting |
NCT04237389 -
Thoracoscopic Ablation Versus Catheter Ablation in Patients With Atrial Fibrillation
|
N/A | |
Terminated |
NCT04206917 -
MultiPulse Therapy (MPT) for AF
|
N/A | |
Not yet recruiting |
NCT05883722 -
Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation
|
N/A |